At the time of writing, Hims & Hers Health Inc [HIMS] stock is trading at $19.44, up 10.08%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HIMS shares have gain 5.54% over the last week, with a monthly amount glided 42.42%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on August 22, 2024, when Needham initiated its Buy rating and assigned the stock a price target of $24. Previously, Imperial Capital downgraded its rating to In-line on August 09, 2024. On May 22, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $20 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $15 on April 16, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $20 as its price target on April 10, 2024. Imperial Capital upgraded its rating to Outperform for this stock on February 28, 2024, but kept the price target unchanged to $16. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $10 on this stock.
For the past year, the stock price of Hims & Hers Health Inc fluctuated between $5.65 and $25.74. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $19.44 at the most recent close of the market. An investor can expect a potential drop of -17.7% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
According to Hims & Hers Health Inc [NYSE:HIMS], the company’s sales were 1.07B for trailing twelve months, which represents an 51.82% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.70 points at the first support level, and at 17.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.08, and for the 2nd resistance point, it is at 20.73.
Ratios To Look Out For
It is important to note that Hims & Hers Health Inc [NYSE:HIMS] has a current ratio of 2.68. In addition, the Quick Ratio stands at 2.30 and the Cash Ratio stands at 1.19. Considering the valuation of this stock, the price to sales ratio is 3.94, the price to book ratio is 11.64 and price to earnings (TTM) ratio is 259.89.
Transactions by insiders
Recent insider trading involved Melissa Baird, Officer, that happened on Oct 07 ’24 when 58750.0 shares were purchased. Chief Executive Officer, Dudum Andrew completed a deal on Oct 01 ’24 to sell 0.19 million shares. Meanwhile, Chief Executive Officer Dudum Andrew sold 0.14 million shares on Oct 01 ’24.
